Thank you for contacting us! We will be in touch soon! In the meantime, feel free to continue browsing our site.
Events
- Experts in Genetically Engineered Animal Development and Maintenance | September 19, 2019
- Symposium: Future of Biologic Drug Discovery and Development | June 13, 2019
News
- Biocytogen is Featured in GEN’s Immunotherapy and Cancer Supplement Issue | April 10, 2020
- Biocytogen CEO’s Response During COVID-19 Pandemic | April 08, 2020
- Gene Targeting Service Verified with Industry-leading Quality Control Measures | March 12, 2020
- GEN Magazine Mentions Biocytogen and Its Humanized Mice Model | March 06, 2020
- Nature Research Webcast: Accelerating therapeutic antibody discovery with fully human antibody mice | November 26, 2019
- The Utility of the Rosa26 Knock-in Mouse | November 19, 2019
- RenMab™ Mouse Featured in GEN Magazine | November 08, 2019
- Biocytogen’s RenMab™ Mouse is Featured on Fiercebiotech | October 28, 2019
- Biocytogen Closes $79M Series D Funding | August 09, 2019
- Biocytogen’s President & CEO, Dr. Yuelei Shen, Speaks at Harvard China Forum at Harvard University | April 15, 2019
- Biocytogen’s Integrated One-stop Preclinical Services and the RenMab Mouse Shine at AACR 2019 | April 07, 2019
